Novel blood-based screening for colorectal cancer less effective, less cost-effective compared to colonoscopies or stool tests

A projected impact and cost-effectiveness analysis estimated reductions in colorectal cancer (CRC) incidence and mortality with novel blood-based and stool-based CRC screening tests versus established alternatives.